Analyst Ratings for Vanda Pharmaceuticals (VNDA) [Sells]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/16/2020 | Oppenheimer | Esther Rajavelu | Downgrade | Underperform (Perform) |
N/A (N/A) |
10.24 (5.24) |
-48.83% | Details |
